News | October 25, 2013

Cardiovascular Research Foundation Appoints Jack Lewin as CEO

Healthcare executive takes helm at interventional cardiology foundation

October 25, 2013 — The Cardiovascular Research Foundation (CRF) announced the appointment of John (Jack) Lewin, M.D., as the foundation’s president and CEO. Lewin was also appointed to CRF’s board of directors. CRF believes Lewin brings a unique blend of leadership and management skills to the organization. He succeeds William Himmelsbach, who retired in late 2012. Colette Gardner, CRF board member, served as president and co-chair of the Executive Leadership Council in the interim.
“Since its inception in 1990, CRF has played a major role in the great progress that has been made in interventional cardiology, and in realizing dramatic improvements in the lives of countless patients by establishing the safe use of new technologies and therapies for heart disease,” said Lewin. “I look forward to working with CRF’s iconic physicians who are so passionate about advancing the field. The combination of preclinical research, clinical trials and excellence in education under one roof gives the foundation a distinctive ability to generate important research questions, test and refine groundbreaking new therapies, and ensure that these therapies are available to patients at the earliest possible opportunity.”
“Jack Lewin’s distinguished background and remarkably innovative tenure as CEO of the American College of Cardiology make him an exceptional individual for this position,” said Eric Woldenberg, chairman, CRF board of directors and senior partner, Pryor Cashman LLP.  “His proven leadership skills, along with his expertise in both the business and clinical aspects of health care, will enable him to help us strengthen and expand our role in the development of new technologies and therapies that will benefit people with heart disease worldwide.” 
Lewin served as CEO of the American College of Cardiology (ACC) from 2006 to April 2012. Prior to the ACC, Lewin was CEO of the California Medical Association for eight years. Previously, he was Hawaii’s director of health from 1986-1994, overseeing 6,500 employees, 12 hospitals and a $1 billion budget. Before that, as a commissioned officer in the U.S. Public Health Service, Lewin was the founder and first director of the Navajo Nation Department of Health, serving the needs of America’s largest Indian tribe. He currently serves as the voluntary chairman of the board for the National Coalition on Health Care. In 2011, he was named as one of Modern Healthcare’s 100 most influential people in Healthcare.
For more information:

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init